Instrument Used: LCMS-8040
The University of Geneva has a long history and is the second largest university in Switzerland. Like many universities in Switzerland, it has a very strong science program. A Shimadzu employee currently studying in the research laboratory there recently conducted an interview with Professor Hopfgartner regarding the LCMS-8040. In addition to the LCMS-8040, the laboratory also uses other Shimadzu LC systems, such as Nexera and Prominence systems.
Life Sciences Mass Spectrometry, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland
What topics are being researched at this laboratory?
Is the Nexera/LCMS-8040 system being utilized effectively? In what ways has it been helpful?
What are the strengths of the Nexera/LCMS-8040 systems?
Do you think such strengths are sufficient to attract the interest of the large pharmaceutical manufacturers in Switzerland?
Do you think such strengths would be helpful to other customers involved in healthcare?
Are there any performance capabilities or functionality of the Nexera/LCMS-8040 that you think need to be improved, added, or expanded?
Do you have any opinions or requests regarding Shimadzu's technology, products, or support?
What sort of impression do you have of Shimadzu Corporation?
What are your dreams regarding your research? How can Shimadzu help achieve those dreams?
Thank you for your comments. We look forward to your ongoing patronage.
Comments About the Interview
The LCMS-8040 is a triple quadrupole LCMS system that offers both fast scan speeds (15,000 u/sec) and fast polarity switching (15 ms). In combination with a Nexera ultra high performance liquid chromatograph, the system achieves both ultra fast analysis and the high reliability of a mass spectrometer.
To ensure this system is useful in drug discovery and clinical testing fields, where high throughput is required, we intend to offer a broad array of comprehensive application packages, including pretreatment, based on the valuable advice and guidance by Professor Hopfgartner.